Honokiol inhibits both constitutive and inducible STAT3 activation and reduces the mRNA expression of STAT3 target genes (Bcl-2, cyclin D1, and survival) in myeloid leukemia cells in a concentration-dependent manner (Bi et al., 2015). Here, STAT3 is linked to myeloid leukemia.